Despite mounting clinical evidence for art therapy, nature therapy, music therapy, and dance therapy, Social Prescriptions remain on the periphery of U.S. healthcare. But the issue may not be proof of concept — it’s proof of value.

This episode argues that Social Prescriptions should be seen not just as wellness tools, but as strategic levers for economic development, long-term cost savings, and workforce readiness. If we want to see Social Prescriptions scale in the U.S., we need to speak the language of systems, incentives, and return on investment.

We unpack the Federal Reserve’s own commentary on “missing markets” — the gap between high-impact community solutions and the formal infrastructure needed to scale them — and show how Social Prescriptions fit squarely in that space.

From Park Rx programs that drive traffic and funding to public lands, to creative therapies that improve mental health while stimulating local economies, Social Prescriptions are already creating real impact. But until that impact is economically legible, it will likely remain unrecognized — and less than scalable.

Send us a text

Support the show